1Di Micco P,Di Micco B.Up-date on solitary plasmacytoma and its main differences with multiple myeloma[J].Exp Oncol,2005,27(1):7-12.
2Dimopoulos MA,Moulopoulos LA,Maniatis A,et al.Solitary plasmacytoma of bone and asymptomatic multiple myeloma[J].Blood,2000,96 (6):2037-2044.
3Schirrmeister H,Buck AK,Bergmann L,et al.Positron emission tomography (PET) for staging of solitary plasmacytoma[J].Cancer Biother Radiopharm,2003,18 (5):841-845.
4Knobel D,Zouhair A,Tsang RW,et al.Prognostic factors in solitary plasmacytoma of the bone:a multicenter rare cancer network study[J].BMC Cancer,2006,6:118 -226.
5Tsang RW,Gospodarowicz MK,Pintilie M,et al.Solitary plasmacytoma treated with radiotherapy:impact of tumor size on outcome[J].Int J Radiat Oncol Biol Phys,2001,50:113-120.
6Dimopoulos MA,Hamilos G.Solitary bone plasmacytoma and extramedullary plasmacytoma[J].Current Treatment Options Oncol,2002,3:255-259.
7Liebross RH,Ha CS,Cox JD,et al.Solitary bone plasmacytoma:outcome and prognostic factors following radiotherapy[J].Int J Radiat Oncol Biol Phys,1998,41:1063-1067.
8Ozsahin M,Tsang RW,Poortmans P,et al.Outcomes and patterns of failure in solitary plasmacytoma:a multicenter rare cancer network study of 258 patients[J].Int J Radiat Oncol Biol Phys,2006,64(1):210-217.
9Wilder RB,Ha CS,Cox JD,et al.Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone[J].Cancer,2002,94(5):1532-1537.
